Västra Hamnen Market Focus Feed

2026-09-08 12:00:00 Precise Biometrics: Fused, funded and focused

2026-09-08 09:30:00 Västra Hamnen Möter - Inission

2026-09-07 09:30:00 Gabather: Awaiting progress after a quiet summer

2026-09-03 09:47:00 Xintela: Exploring paths for XSTEM OA

2026-09-03 09:30:00 Glycorex nya vd om Q2 och framtiden

2026-09-02 15:30:00 Gabather presents Q2 2026

2026-09-02 15:00:00 aXichem on aXiphen in Europe

2026-08-31 09:30:00 aXichem: Milstolpe uppnådd, lansering i sikte

2026-08-28 12:00:00 Intervju med Precise Biometrics om Q2 2026

2026-08-28 08:00:00 aXichem presenterar Q2 2026

2026-08-26 08:00:00 Bioextrax: Taking steps in the right direction

2026-08-25 14:30:00 Bioextrax presenterar Q2 2026

2026-08-24 15:00:00 Kentima: Bygger vidare på stark efterfrågan

2026-08-24 14:00:00 Crunchfish: In transition from pilots to contracts

2026-08-21 12:31:00 Crunchfish comments on Q2 2026

2026-08-05 13:53:00 Precise Biometrics om emissionen 2026

2026-07-31 14:11:00 Fortsatt tillväxtfokus efter svagt Q1

2026-07-27 16:30:00 aXichem kommenterar utlåtande från EFSA

2026-07-20 11:00:00 Advenica: Weaker Q2 despite record service revenues

2026-07-17 14:15:00 Advenica kommenterar Q2 2026

2026-07-01 10:09:00 CHOSA Oncology in connection with the TO2 warrant exercise

2026-06-04 14:15:00 Precise Biometrics: MOSIP compliancy adds potential

2026-06-04 08:45:00 USWE Sports: Uppdaterade finansiella mål

2026-06-04 08:00:00 Xintela: Completing another phase I/IIa study

2026-06-02 08:00:00 Gabather: Phase II finally activated

2026-06-01 14:00:00 Gabather presents Q1 2026

2026-05-26 09:00:00 Crunchfish: Quiet quarter, busy pipeline

2026-05-25 14:45:00 aXichem: I väntan på EFSA

2026-05-25 13:00:00 Bioextrax: Deals taking shape

2026-05-22 17:00:00 aXichem presenterar Q1 2026

2026-05-22 13:00:00 Bioextrax presenterar Q1 2026

2026-05-21 10:45:00 Crunchfish comments on the Q1 report

2026-05-19 13:00:00 Precise Biometrics: Supporting the merger

2026-05-15 09:30:00 Intervju med Precise Biometrics om Q1 2026

2026-05-11 14:35:00 Kentima: Håller kursen mot ökad lönsamhet

2026-05-08 08:00:00 Gabather: Starting phase II clinical trial

2026-04-29 15:00:00 Advenica: Filling the pipeline

2026-04-28 14:45:00 Advenica kommenterar Q1 2026

2026-04-10 16:00:00 Gabather comments on the new patent application

2026-04-09 09:45:00 Lyckegårds ordförande om 2025 och framåt

2026-03-27 13:50:00 Precise Biometrics: Merger with Fingerprint Cards

2026-03-25 12:17:00 Precise Biometrics om fusionen med FPC

2026-03-25 08:00:00 En ny krydda i mjölkproduktionen

2026-03-23 08:00:00 Kentima: Rabatt på skalbar lönsamhet

2026-03-19 10:00:00 Gabather: Key shareholders show support

2026-03-03 15:00:00 Gabather: Any day now

2026-03-03 13:30:00 Gabather presents Q4 2025

2026-03-03 09:15:00 Xintela: Moving forward with XSTEM

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode